3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
19
Neoplasms
11
Polycystic Ovary Syndrome
9
Neoplasm Metastasis
4
Multiple Myeloma
4
Melanoma
4
Vomiting
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Skin Neoplasms
2
Sarcoma
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peripheral Nervous System Diseases
2
Ovarian Neoplasms
2
Obesity
2
Nausea
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Leukemia
2
Insulin Resistance
2
Inflammation
2
Diabetes Mellitus
2
Colorectal Neoplasms
2
Cognitive Dysfunction
2
Interventions
Radiotherapy
2
Exercise
2
Deglutition
2
Cisplatin
2
Carboplatin
2
Brachytherapy
2
Acupuncture Therapy
2
tislelizumab
1
epigallocatechin gallate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Tablets
1
Standard of Care
1
Resistance Training
1
Range of Motion, Articular
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Pravastatin
1
Paclitaxel
1
Niacinamide
1
Musculoskeletal Manipulations
1
Lead
1
Hyaluronic Acid
1
Gastropexy
1
Fundoplication
1
Fluorouracil
1
Fibroblast Growth Factor 7
1
Esophagectomy
1
Endoscopy, Digestive System
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Deglutition Disorders
×
Tablets
×
Clear all
NCT07217938
2026-03-03
TRADstat
Peter MacCallum Cancer Centre, Australia
Phase 2
Recruiting
48 enrolled